InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: christjamin post# 40213

Sunday, 01/22/2017 11:06:13 AM

Sunday, January 22, 2017 11:06:13 AM

Post# of 203913
Take a look at the revenue pipeline. I don't think $20 is unrealistic within 1 year.

In 2 years OWCP could have:

A sublingual tablet to treat Multiple Myeloma cancer.

A sublingual tablet to treat PTSD.

A sublingual tablet to treat Migraines.

A sublingual tablet to treat Fibromyalgia.

A topical cream to treat Psoriasis. (Revenue starting in Q3)

A topical cream to treat Acne.

A topical cream to treat Basal Cell Carcinoma.

A topical cream to treat Atopic Dermatitis.

Government consulting contracts. (3 contracts already signed)

Licensing agreements on their tablet, cream, and nasal spray delivery systems.

Look at the valuations of AXIM and GWPH and compare the pipelines of those companies to OWCP's pipeline. Does it really seem correct to compare OWCP with AXIM and GWPH?

The million dollar question is, knowing what is on the very bright horizon for OWCP, what will analysts' valuation be. $20 seems very reasonable to me.